Dashboard
Manage Tickers

RNAAvidity Biosciences, Inc.

Nasdaq aviditybiosciences.com


$ 46.44 $ -0.81 (-1.71 %)    

Friday, 09-Aug-2024 11:49:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 448.58 $ 2.81 (0.63 %)
DIA $ 394.58 $ 0.06 (0.02 %)
SPY $ 531.45 $ 2.82 (0.53 %)
TLT $ 96.28 $ 0.13 (0.13 %)
GLD $ 224.79 $ -0.04 (-0.02 %)
$ 41.87
$ 47.25
$ 46.29 x 100
-- x --
$ 43.48 - $ 47.25
$ 4.83 - $ 48.80
688,074
na
3.65B
$ 1.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

avidity-biosciences-says-data-suggest-del-zota-has-potential-to-change-treatment-paradigm-and-course-of-disease-for-patients-with-duchenne-muscular-dystrophy-mutations-amenable-to-exon-44-skipping
Avidity Biosciences Says Data Suggest del-...
08/09/2024 11:15:59

AOC 1044 demonstrated favorable safety and tolerability. Avidity also announced delpacibart zotadirsen as the approved internat...

genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected
GeneDx Leads Russell 2000 This Year As It ...
08/02/2024 18:06:16

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected
GeneDx Leads Russell 2000 This Year As It ...
08/02/2024 18:06:16

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

top-performing-industry-etfs-in-june-software-leads-returns-chipmakers-attract-most-inflows
Top Performing Industry ETFs In June: Soft...
07/01/2024 17:38:29

June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while ut...

rna---analyzing-avidity-biosciencess-short-interest
(RNA) - Analyzing Avidity Biosciences's Sh...
06/20/2024 15:45:19

avidity-biosciences-and-cleanspark-were-among-the-10-biggest-mid-cap-stock-gainers-last-week-june-9-june-15-are-these-in-your-portfolio
Avidity Biosciences And CleanSpark Were Am...
06/16/2024 18:25:10

Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, Cle...

adobe-avidity-biosciences-and-3-stocks-to-watch-heading-into-friday
Adobe, Avidity Biosciences And 3 Stocks To...
06/14/2024 10:08:09

reported-earlier-avidity-biosciences-prices-4009m-public-offering-of-1055m-common-shares-at-38share
Reported Earlier, Avidity Biosciences Pric...
06/14/2024 06:38:19

All of the shares to be sold in the offering are to be sold by Avidity. The gross proceeds to Avidity from the offering, before...

b-of-a-securities-maintains-buy-on-avidity-biosciences-raises-price-target-to-45
B of A Securities Maintains Buy on Avidity...
06/13/2024 16:08:41

B of A Securities analyst Geoff Meacham maintains Avidity Biosciences (NASDAQ:RNA) with a Buy and raises the price target fr...

avidity-bioscience-announces-proposed-public-offering-of-300m-of-common-stock
Avidity Bioscience Announces Proposed Publ...
06/12/2024 20:01:45

needham-maintains-buy-on-avidity-biosciences-raises-price-target-to-46
Needham Maintains Buy on Avidity Bioscienc...
06/12/2024 19:35:59

Needham analyst Joseph Stringer maintains Avidity Biosciences (NASDAQ:RNA) with a Buy and raises the price target from $35 t...

crude-oil-moves-higher-vera-bradley-shares-slide
Crude Oil Moves Higher; Vera Bradley Share...
06/12/2024 18:38:59

chardan-capital-maintains-buy-on-avidity-biosciences-raises-price-target-to-45
Chardan Capital Maintains Buy on Avidity B...
06/12/2024 18:08:32

Chardan Capital analyst Keay Nakae maintains Avidity Biosciences (NASDAQ:RNA) with a Buy and raises the price target from $3...

evercore-isi-group-maintains-outperform-on-avidity-biosciences-raises-price-target-to-45
Evercore ISI Group Maintains Outperform on...
06/12/2024 17:52:05

Evercore ISI Group analyst Josh Schimmer maintains Avidity Biosciences (NASDAQ:RNA) with a Outperform and raises the price t...

why-streamline-health-solutions-shares-are-trading-lower-by-23-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Streamline Health Solutions Shares Are...
06/12/2024 17:25:48

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/12/2024 16:31:05

nasdaq-jumps-300-points-oracle-shares-spike-higher
Nasdaq Jumps 300 Points; Oracle Shares Spi...
06/12/2024 16:06:12

why-avidity-biosciences-shares-are-trading-higher-wednesday
Why Avidity Biosciences Shares Are Trading...
06/12/2024 15:15:22

The 39 patient trial was in relation to treating facioscapulohumeral muscular dystrophy (FSHD) with delpacibart braxlosiran.

caseys-reports-upbeat-earnings-joins-avidity-biosciences-rentokil-initial-and-other-big-stocks-moving-higher-on-wednesday
Casey's Reports Upbeat Earnings, Joins Avi...
06/12/2024 14:15:52

Core News & Articles
Market-Moving News for June 12th
06/12/2024 12:49:59

BMR: 56% | Beamr Says Its Cloud Solution Is Now Available In The Oracle Cloud Marketplace; Provides AI-Ready Video Processing S...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION